rs869320762
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_016222.4(DDX41):c.435-2_435-1delAGinsCA variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_016222.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DDX41 | NM_016222.4 | c.435-2_435-1delAGinsCA | splice_acceptor_variant, intron_variant | Intron 5 of 16 | ENST00000330503.12 | NP_057306.2 | ||
DDX41 | NM_001321732.2 | c.57-2_57-1delAGinsCA | splice_acceptor_variant, intron_variant | Intron 4 of 15 | NP_001308661.1 | |||
DDX41 | NM_001321830.2 | c.57-2_57-1delAGinsCA | splice_acceptor_variant, intron_variant | Intron 5 of 16 | NP_001308759.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Canonical splice site variant demonstrated to result in aberrant splicing resulting in a null allele in a gene for which loss of function is a known mechanism of disease (PMID: 26712909); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28637623, 32054657, 26712909, 33850299) -
This sequence change affects a splice site in intron 5 of the DDX41 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or altered protein product. Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database. Disruption of this splice site has been observed in individual(s) with DDX41-related conditions (PMID: 26712909, 32054657, 33850299). ClinVar contains an entry for this variant (Variation ID: 224636). Studies have shown that disruption of this splice site results in skipping of exon 6 and/or partial retention of intron 6, and produces a non-functional protein and/or introduces a premature termination codon (PMID: 26712909). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
This sequence change affects the canonical acceptor splice site of intron 5 and is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated DDX41 protein with potentially abnormal function. This sequence change appears to be novel and does not appear to have been described in patients or the normal population databases. This sequence change is predicted to be likely pathogenic, however functional studies have not been performed to prove this conclusively. This patient is a carrier of this likely pathogenic sequence change in DDX41. Germline mutations in DDX41 are associated with the development of hereditary myelodysplastic syndrome and acute myeloid leukemia. Our interpretation is based on the current understanding of the genetics of DDX41-related myeloid neoplasms. -
DDX41-related hematologic malignancy predisposition syndrome Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at